The Readout Loud

302: Vertex's big deal, biotech's red numbers, & an industry history lesson

Apr 11, 2024
Discussing Vertex's $13 billion deal, biotech's struggles, Dendreon's history, and gas prices impact. Exploring industry performance, market reflections, and a surprise announcement. Fond farewell to Damien with heartfelt tributes, banter, and technical discussions.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 3min
2
Exploring Vertex's Acquisition and Alpine Immune Scientists' CEO History
02:38 • 4min
3
Biotech Industry Performance and Market Reflections
06:47 • 5min
4
Remembering Damien: A Fond Farewell
11:26 • 12min
5
Playful Host Banter and Technical Testing
23:06 • 2min